← feed

Is NCT03630094 results overdue?

Yes — results are overdue. Primary completion was 2017-06-30; the FDAAA-801 reporting deadline (2018-06-30) passed 2913 days ago and no results are posted on ClinicalTrials.gov.

Plasma and Intrapulmonary Concentrations Study of WCK 5222

NCT IDNCT03630094 ↗
SponsorWockhardt (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-06-30 (ACTUAL)
Reporting deadline2018-06-30 (completion + 365d)
Days overdue2913
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 1eee219b3fd8dce1… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03630094. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →